These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 11651480)
1. Community consultation and AIDS clinical trials; part II. Spiers HR IRB; 1991; 13(4):1-6. PubMed ID: 11651480 [No Abstract] [Full Text] [Related]
2. Community consultation and AIDS clinical trials, part I. Spiers HR IRB; 1991; 13(3):7-10. PubMed ID: 11651047 [No Abstract] [Full Text] [Related]
3. Community consultation and AIDS clinical trials: part III. Spiers HR IRB; 1991; 13(5):3-7. PubMed ID: 11651249 [No Abstract] [Full Text] [Related]
4. The construction of lay expertise: AIDS activism and the forging of credibility in the reform of clinical trials. Epstein S Sci Technol Human Values; 1995; 20(4):408-37. PubMed ID: 11653331 [No Abstract] [Full Text] [Related]
5. The need for improved access to experimental drug therapy: AIDS activists and their call for a parallel track policy. Terrizzi L Adm Law J; 1991; 4(3):589-634. PubMed ID: 11659598 [No Abstract] [Full Text] [Related]
6. Community-based AIDS research. Merton V Eval Rev; 1990 Oct; 14(5):502-37. PubMed ID: 11656281 [No Abstract] [Full Text] [Related]
7. Stigma, conflict, and the approval of AIDS drugs. Hansen RW; Ranelli PL; Ried LD J Drug Issues; 1995; 25(1):129-39. PubMed ID: 11653301 [No Abstract] [Full Text] [Related]
8. Building a new consensus: ethical principles and policies for clinical research on HIV/AIDS. Levine C; Dubler NN; Levine RJ IRB; 1991; 13(1-2):1-17. PubMed ID: 11659323 [No Abstract] [Full Text] [Related]
9. New rules for new drugs: the challenge of AIDS to the regulatory process. Edgar H; Rothman DJ Milbank Q; 1990; 68(Suppl. 1):111-42. PubMed ID: 11650413 [TBL] [Abstract][Full Text] [Related]
10. The role of community advisory committees in clinical trials of anti-HIV agents. Valdiserri RO; Tama GM; Ho M IRB; 1988; 10(4):5-7. PubMed ID: 11650079 [No Abstract] [Full Text] [Related]
11. Faith (healing), hope and charity at the FDA: the politics of AIDS drug trials. Annas GJ Villanova Law Rev; 1989 Sep; 34(5):771-97. PubMed ID: 11651162 [No Abstract] [Full Text] [Related]
12. AIDS clinical trials: ethical and design issues. Schüklenk U; Hogan C J Int Bioethique; 1997 Sep; 8(3):127-32. PubMed ID: 11655232 [No Abstract] [Full Text] [Related]
13. Shaking up the status quo: how AIDS activists have challenged drug development and approval procedures. Dunbar MM Food Drug Cosmet Law J; 1991 Sep; 46(5):673-706. PubMed ID: 11651380 [No Abstract] [Full Text] [Related]
14. Some ethical issues associated with HIV vaccine trials. Novick A AIDS Public Policy J; 1988; 3(3):46-8. PubMed ID: 11650102 [No Abstract] [Full Text] [Related]
15. Estimating risks and benefits in AIDS vaccine and drug trials. Kessel E AIDS Public Policy J; 1990; 5(4):186-8. PubMed ID: 11650977 [No Abstract] [Full Text] [Related]
16. Cross-cultural ethics in the conduct of deafness research. Pollard RQ Rehabil Psychol; 1992; 37(2):87-101. PubMed ID: 11659590 [No Abstract] [Full Text] [Related]
17. Public deliberation and scientific expertise. Wachbroit R Rep Inst Philos Public Policy; 1998; 18(4):17-23. PubMed ID: 11657727 [No Abstract] [Full Text] [Related]
18. AIDS and the FDA: an ethical case for limiting patient access to new medical therapies. Shorr AF IRB; 1992; 14(4):1-5. PubMed ID: 11651391 [No Abstract] [Full Text] [Related]
19. AIDS: patient power puts research on trial. Campbell D New Sci; 1988 Nov; 120(1638):26-7. PubMed ID: 11655899 [No Abstract] [Full Text] [Related]
20. Twice wrong on AIDS. Gieringer D N Y Times Web; 1987 Jan; ():A21. PubMed ID: 11646161 [No Abstract] [Full Text] [Related] [Next] [New Search]